Regeneron Pharmaceuticals, Inc. (REGN)
769.37
-18.13
(-2.30%)
USD |
NASDAQ |
Mar 05, 09:56
Regeneron Pharmaceuticals Free Cash Flow : 3.765B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 12.36B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.171B |
| Cash from Investing (Quarterly) | 220.30M |
| Cash from Financing (Quarterly) | -780.10M |
| Free Cash Flow Per Share (Quarterly) | 8.186 |
| Free Cash Flow to Equity (Quarterly) | 612.80M |
| Free Cash Flow to Firm (Quarterly) | 889.87M |
| Free Cash Flow Yield | 4.51% |